Clinical Trial Update: Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating pulsatile insulin delivery for diabetic neuropathy in patients with type 1 or type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Diabetes Mellitus, With Complications | Phase 2, Phase 3 | Status: TERMINATED